Xiang Xiao
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Immunology top 10%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 2
- Oncology top 10%
- Gastroenterology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- Liver Disease Diagnosis and Treatment 3
-
- Glioma Diagnosis and Treatment 2
-
- Gastric Cancer Management and Outcomes 2
- Cited by
- HepatologyImmunologyCancer Research
In The Last Decade
Xiang Xiao
24 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hepatology 239
- Immunology 346
- Cancer Research 245
- Oncology 410
- Gastroenterology 68
Countries citing papers authored by Xiang Xiao
This map shows the geographic impact of Xiang Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Xiao more than expected).
Fields of papers citing papers by Xiang Xiao
This network shows the impact of papers produced by Xiang Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Xiao. The network helps show where Xiang Xiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiang Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 6 | |
| 12 | Liver tumour immune microenvironment subtypes and neutrophil heterogeneitybreakdown → | 2022 | 494 |
| 13 | 2021 | 30 | |
| 14 | 2021 | 48 | |
| 15 | 2021 | 11 | |
| 16 | 2020 | 86 | |
| 17 | 2019 | 54 | |
| 18 | 2017 | 20 | |
| 19 | 2012 | 78 | |
| 20 | 2007 | 4 |
About Xiang Xiao
Xiang Xiao is a scholar working on Hepatology, Cancer Research and Gastroenterology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Glioma Diagnosis and Treatment (2 papers), MicroRNA in disease regulation (2 papers), Cancer Genomics and Diagnostics (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Hepatology (239 citations), Immunology (346 citations) and Cancer Research (245 citations). Xiang Xiao has collaborated with scholars based in China, Italy and Hong Kong. Frequent co-authors include Jiye Zhu, Ruidong Xue, Ning Zhang, Jinghui Cheng, Hengkang Liu, Qi Cao, Mei Feng, Ruirui Kong, Zemin Zhang and Li Zhao. Their work appears in journals such as Nature, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.